ALAMYCIN LA 300 MG/ML SOLUTION FOR INJECTION

Država: Irska

Jezik: angleščina

Source: HPRA (Health Products Regulatory Authority)

Aktivna sestavina:

OXYTETRACYCLINE BASIC

Dostopno od:

Norbrook Laboratories Limited

Koda artikla:

QJ01AA06

INN (mednarodno ime):

OXYTETRACYCLINE BASIC

Odmerek:

300 Mg/Ml

Farmacevtska oblika:

Solution for Injection

Tip zastaranja:

POM

Terapevtska skupina:

Bovine, Ovine, Porcine

Terapevtsko območje:

Oxytetracycline

Terapevtske indikacije:

Antibacterial

Status dovoljenje:

Authorised

Datum dovoljenje:

1994-02-10

Lastnosti izdelka

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Alamycin LA 300 mg/ml Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
Active Substance:
Oxytetracycline base
300 mg
(as Oxytetracycline dihydrate)
Excipients:
Sodium Formaldehyde Sulphoxylate
4.0 mg
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, pigs and sheep.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment and control of conditions caused by, or associated with, organisms sensitive to oxytetracycline
including:
_Bordetella bronchiseptica_
_Actinomyces pyogenes_
_Erysipelothrix rhusiopathiae_
_Pasteurella _spp.
_Staphylococcus _spp.
_Streptococcus _spp.
Certain mycoplasma, rickettsiae, protozoa and chlamydia.
Alamycin LA 300 may be used in the treatment and control of a wide range of common systemic, respiratory, urinary
and local infections caused by oxytetracycline sensitive organisms. Specific indications for Alamycin LA 300 include:
pasteurellosis, pneumonia, atrophic rhinitis, erysipelas, joint-ill, navel-ill, supportive therapy in bovine mastitis, ovine
keratoconjunctivitis (pink-eye) and enzootic abortion in sheep.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 21/12/2015_
_CRN 7022548_
_page number: 1_
4.3 CONTRAINDICATIONS
Do not dilute the Alamycin LA 300.
Do not use in animals with known hypersensitivity to the active ingredient.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
No special warnings.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTION(S) FOR USE IN ANIMALS
If concurrent treatment is administered use a separate injection site.
Use of the product should be based